Skip to main content
Erschienen in: Metabolic Brain Disease 5/2017

07.04.2017 | Original Article

Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I

verfasst von: Ahmed Mosaeilhy, Magdy M. Mohamed, George Priya Doss C, Heba S. A. El Abd, Radwa Gamal, Osama K. Zaki, Hatem Zayed

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Glutaric acidemia I (GAI) is an autosomal recessive metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (GCDH). Patients with GAI are characterized by macrocephaly, acute encephalitis-like crises, dystonia and frontotemporal atrophy. In this study, we investigated 18 Egyptian patients that were diagnosed with GAI based on their clinical, neuroradiological, and biochemical profiles. Of the 18 patients, 16 had developmental delay and/or regression, dystonia was prominent in 75% of the cases, and three patients died. Molecular genetics analysis identified 14 different mutations in the GCDH gene in the 18 patients, of the 14 mutations, nine were missense, three were in the 3′-Untranslated Region (3′-UTR), one was nonsense, and one was a silent mutation. Four novel mutations were identified (c.148 T > A; p.Trp50Arg, c.158C > A; p.Pro53Gln, c.1284C > G; p.Ile428Met, and c.1189G > T; p.Glu397*) that were all absent in 300 normal chromosomes. The 3′-UTR mutation (c.*165A > G; rs8012), was the most frequent mutation observed (0.5; 18/36), followed by the most common mutation among Caucasian patients (p.Arg402Trp; rs121434369) with allele frequency of 0.36 (13/36), and the 3′-UTR mutation (c.*288G > T; rs9384, 0.22; 8/16). The p.Arg257Gln mutation was found with allele frequency of ~0.17 (6/36). The marked homozygosity observed in our patients is probably due to the high level of consanguinity that is observed in 100% of the cases. We used nine in silico prediction tools to predict the pathogenicity (SIFT, PhD-SNP, SNAP, Meta-SNP, PolyPhen2, and Align GVGD) and protein stability (I-Mutant2.0, Mupro, and istable) of the nine missense mutants. The mutant p.Arg402Trp was predicted to be most deleterious by all the six pathogenicity prediction tools and destabilizing by all the three-stability prediction tools, and highly conserved by the ConSurf server. Using the clinical, biochemical, family history of the 18 patients, and the in silico analysis of the missense mutations, our study showed a mix of conclusive and inconclusive genotype-phenotype correlations among our patient’s cohort and suggests the usefulness of using various sophisticated computational analysis to be utilized for future variant classifications in the genetic clinics.
Literatur
Zurück zum Zitat Adzhubei, I., D. M. Jordan and S. R. Sunyaev (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7: Unit7.20. Adzhubei, I., D. M. Jordan and S. R. Sunyaev (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7: Unit7.20.
Zurück zum Zitat Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, George Priya Doss C (2016) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn:1–11 Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, George Priya Doss C (2016) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn:1–11
Zurück zum Zitat Baric I, Wagner L, Feyh P, Liesert M, Buckel W et al (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22:867–881CrossRefPubMed Baric I, Wagner L, Feyh P, Liesert M, Buckel W et al (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22:867–881CrossRefPubMed
Zurück zum Zitat Biery BJ, Stein DE, Morton DH, Goodman SI (1996) Gene structure and mutations of glutaryl-coenzyme a dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet 59:1006–1011PubMedPubMedCentral Biery BJ, Stein DE, Morton DH, Goodman SI (1996) Gene structure and mutations of glutaryl-coenzyme a dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet 59:1006–1011PubMedPubMedCentral
Zurück zum Zitat Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ et al (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507CrossRefPubMed Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ et al (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507CrossRefPubMed
Zurück zum Zitat Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H et al (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291CrossRefPubMed Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H et al (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291CrossRefPubMed
Zurück zum Zitat Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C et al (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73–77CrossRefPubMed Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C et al (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73–77CrossRefPubMed
Zurück zum Zitat Busquets C, Merinero B, Christensen E, Gelpi JL, Campistol J et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322CrossRefPubMed Busquets C, Merinero B, Christensen E, Gelpi JL, Campistol J et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322CrossRefPubMed
Zurück zum Zitat Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306–W310CrossRefPubMedPubMedCentral Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306–W310CrossRefPubMedPubMedCentral
Zurück zum Zitat Capriotti E, Calabrese R, Casadio R (2006) Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729–2734CrossRefPubMed Capriotti E, Calabrese R, Casadio R (2006) Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729–2734CrossRefPubMed
Zurück zum Zitat Capriotti E, Altman RB, Bromberg Y (2013) Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics 14(Suppl 3):S2CrossRefPubMedPubMedCentral Capriotti E, Altman RB, Bromberg Y (2013) Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics 14(Suppl 3):S2CrossRefPubMedPubMedCentral
Zurück zum Zitat Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797–1817CrossRefPubMed Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797–1817CrossRefPubMed
Zurück zum Zitat Chen CW, Lin J, Chu YW (2013) iStable: off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics 14(Suppl 2):S5CrossRef Chen CW, Lin J, Chu YW (2013) iStable: off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics 14(Suppl 2):S5CrossRef
Zurück zum Zitat Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 62:1125–1132CrossRefPubMed Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 62:1125–1132CrossRefPubMed
Zurück zum Zitat Christensen E, Ribes A, Merinero B, Zschocke J (2004) Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:861–868CrossRefPubMed Christensen E, Ribes A, Merinero B, Zschocke J (2004) Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:861–868CrossRefPubMed
Zurück zum Zitat Doss CG, Alasmar DR, Bux RI, Sneha P, Bakhsh FD et al (2016) Genetic epidemiology of glucose-6-dehydrogenase deficiency in the Arab world. Sci Rep 6:37284CrossRefPubMedPubMedCentral Doss CG, Alasmar DR, Bux RI, Sneha P, Bakhsh FD et al (2016) Genetic epidemiology of glucose-6-dehydrogenase deficiency in the Arab world. Sci Rep 6:37284CrossRefPubMedPubMedCentral
Zurück zum Zitat Georgiou T, Nicolaidou P, Hadjichristou A, Ioannou R, Dionysiou M et al (2014) Molecular analysis of Cypriot patients with Glutaric aciduria type I: identification of two novel mutations. Clin Biochem 47:1300–1305CrossRefPubMed Georgiou T, Nicolaidou P, Hadjichristou A, Ioannou R, Dionysiou M et al (2014) Molecular analysis of Cypriot patients with Glutaric aciduria type I: identification of two novel mutations. Clin Biochem 47:1300–1305CrossRefPubMed
Zurück zum Zitat Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D et al (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163–164CrossRefPubMed Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D et al (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163–164CrossRefPubMed
Zurück zum Zitat Goodman SI, Stein DE, Schlesinger S, Christensen E, Schwartz M et al (1998) Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat 12:141–144CrossRefPubMed Goodman SI, Stein DE, Schlesinger S, Christensen E, Schwartz M et al (1998) Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat 12:141–144CrossRefPubMed
Zurück zum Zitat Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC et al (2002) Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75:70–78CrossRefPubMed Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC et al (2002) Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75:70–78CrossRefPubMed
Zurück zum Zitat Gupta N, Singh PK, Kumar M, Shastri S, Gulati S et al (2015) Glutaric Acidemia type 1-Clinico-molecular profile and novel mutations in GCDH Gene in Indian patients. JIMD Rep 21:45–55CrossRefPubMedPubMedCentral Gupta N, Singh PK, Kumar M, Shastri S, Gulati S et al (2015) Glutaric Acidemia type 1-Clinico-molecular profile and novel mutations in GCDH Gene in Indian patients. JIMD Rep 21:45–55CrossRefPubMedPubMedCentral
Zurück zum Zitat Heringer J, Boy SP, Ensenauer R, Assmann B, Zschocke J et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752CrossRefPubMed Heringer J, Boy SP, Ensenauer R, Assmann B, Zschocke J et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752CrossRefPubMed
Zurück zum Zitat Hoffmann GF, Trefz FK, Barth PG, Bohles HJ, Biggemann B et al (1991) Glutaryl-coenzyme a dehydrogenase deficiency: a distinct encephalopathy. Pediatrics 88:1194–1203PubMed Hoffmann GF, Trefz FK, Barth PG, Bohles HJ, Biggemann B et al (1991) Glutaryl-coenzyme a dehydrogenase deficiency: a distinct encephalopathy. Pediatrics 88:1194–1203PubMed
Zurück zum Zitat Kim HS, Yu HJ, Lee J, Park HD, Kim JH et al (2014) A Korean patient with glutaric aciduria type 1 with a novel mutation in the glutaryl CoA dehydrogenase gene. Ann Clin Lab Sci 44:213–216PubMed Kim HS, Yu HJ, Lee J, Park HD, Kim JH et al (2014) A Korean patient with glutaric aciduria type 1 with a novel mutation in the glutaryl CoA dehydrogenase gene. Ann Clin Lab Sci 44:213–216PubMed
Zurück zum Zitat Kolker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRefPubMed Kolker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRefPubMed
Zurück zum Zitat Kolker S, Christensen E, Leonard JV, Greenberg CR, Burlina AB et al (2007) Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 30:5–22CrossRefPubMed Kolker S, Christensen E, Leonard JV, Greenberg CR, Burlina AB et al (2007) Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 30:5–22CrossRefPubMed
Zurück zum Zitat Korman SH, Jakobs C, Darmin PS, Gutman A, van der Knaap MS et al (2007) Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Paediatr Neurol 11:81–89CrossRefPubMed Korman SH, Jakobs C, Darmin PS, Gutman A, van der Knaap MS et al (2007) Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Paediatr Neurol 11:81–89CrossRefPubMed
Zurück zum Zitat Lindner M, Kolker S, Schulze A, Christensen E, Greenberg CR et al (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:851–859CrossRefPubMed Lindner M, Kolker S, Schulze A, Christensen E, Greenberg CR et al (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:851–859CrossRefPubMed
Zurück zum Zitat Mohammad SA, Abdelkhalek HS, Ahmed KA, Zaki OK (2015) Glutaric aciduria type 1: neuroimaging features with clinical correlation. Pediatr Radiol 45:1696–1705CrossRefPubMed Mohammad SA, Abdelkhalek HS, Ahmed KA, Zaki OK (2015) Glutaric aciduria type 1: neuroimaging features with clinical correlation. Pediatr Radiol 45:1696–1705CrossRefPubMed
Zurück zum Zitat Moseilhy A, Hassan MM, El Abd HS, Mohammad SA, El Bekay R et al (2016) Severe neurological manifestations in an Egyptian patient with a novel frameshift mutation in the Glutaryl-CoA dehydrogenase gene. Metab Brain Dis Moseilhy A, Hassan MM, El Abd HS, Mohammad SA, El Bekay R et al (2016) Severe neurological manifestations in an Egyptian patient with a novel frameshift mutation in the Glutaryl-CoA dehydrogenase gene. Metab Brain Dis
Zurück zum Zitat Mushimoto Y, Fukuda S, Hasegawa Y, Kobayashi H, Purevsuren J et al (2011) Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1. Mol Genet Metab 102:343–348CrossRefPubMed Mushimoto Y, Fukuda S, Hasegawa Y, Kobayashi H, Purevsuren J et al (2011) Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1. Mol Genet Metab 102:343–348CrossRefPubMed
Zurück zum Zitat Sneha P, Kumar D, Tanwar H, Siva R, Doss GP et al (2017) Structural analysis of G1691S variant in the human filamin b gene responsible for Larsen syndrome: a comparative computational approach. J Cell Biochem Sneha P, Kumar D, Tanwar H, Siva R, Doss GP et al (2017) Structural analysis of G1691S variant in the human filamin b gene responsible for Larsen syndrome: a comparative computational approach. J Cell Biochem
Zurück zum Zitat Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121c:38–52CrossRefPubMed Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121c:38–52CrossRefPubMed
Zurück zum Zitat Tang NL, Hui J, Law LK, Lam YY, Chan KY et al (2000) Recurrent and novel mutations of GCDH gene in Chinese glutaric acidemia type I families. Hum Mutat 16:446CrossRefPubMed Tang NL, Hui J, Law LK, Lam YY, Chan KY et al (2000) Recurrent and novel mutations of GCDH gene in Chinese glutaric acidemia type I families. Hum Mutat 16:446CrossRefPubMed
Zurück zum Zitat Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295–305CrossRefPubMed Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295–305CrossRefPubMed
Zurück zum Zitat Thong MK, Yunus ZM (2008) Spectrum of inherited metabolic disorders in Malaysia. Ann Acad Med Singap 37:66–65PubMed Thong MK, Yunus ZM (2008) Spectrum of inherited metabolic disorders in Malaysia. Ann Acad Med Singap 37:66–65PubMed
Zurück zum Zitat Wang Q, Li X, Ding Y, Liu Y, Song J et al (2014) Clinical and mutational spectra of 23 Chinese patients with glutaric aciduria type 1. Brain and Development 36:813–822CrossRefPubMed Wang Q, Li X, Ding Y, Liu Y, Song J et al (2014) Clinical and mutational spectra of 23 Chinese patients with glutaric aciduria type 1. Brain and Development 36:813–822CrossRefPubMed
Zurück zum Zitat Zaki OK, El Abd HS, Mohamed SA, Zayed H (2016) Novel mutation in an Egyptian patient with infantile Canavan disease. Metab Brain Dis 31:573–577CrossRefPubMed Zaki OK, El Abd HS, Mohamed SA, Zayed H (2016) Novel mutation in an Egyptian patient with infantile Canavan disease. Metab Brain Dis 31:573–577CrossRefPubMed
Zurück zum Zitat Zaki OK, Krishnamoorthy N, El Abd HS, Harche SA, Mattar RA et al (2017) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32:171–177CrossRefPubMed Zaki OK, Krishnamoorthy N, El Abd HS, Harche SA, Mattar RA et al (2017) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32:171–177CrossRefPubMed
Metadaten
Titel
Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I
verfasst von
Ahmed Mosaeilhy
Magdy M. Mohamed
George Priya Doss C
Heba S. A. El Abd
Radwa Gamal
Osama K. Zaki
Hatem Zayed
Publikationsdatum
07.04.2017
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 5/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0006-4

Weitere Artikel der Ausgabe 5/2017

Metabolic Brain Disease 5/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.